Human Beta-Defensin-2 in Oral Cancer with Opportunistic Candida Infection

Anticancer Research

Volumn 24, Issue 2 B, 2004, Pages 1025-1030

  Meyer, Jens Eduard ^a,c   Harder, Jürgen ^b   Görögh, Tibor ^a   Weise, Jan Bernd ^a   Schubert, Sabine ^b   Janssen, Dirk ^c   Maune, Steffen ^a  

^a Dept of Otorinol Head/Neck Surg   (Germany)

^b Dept Dermatol Venerol/Allergol ^*  (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Antimicrobial peptides; Cancer; Candida; Defensin; hBD 2; Innate immunity

Indexed keywords

BETA DEFENSIN 2;

ARTICLE; CANDIDA ALBICANS; CLINICAL ARTICLE; FIBROBLAST CULTURE; FUNGUS GROWTH; HOST RESISTANCE; HUMAN; HUMAN CELL; MOUTH MUCOSA; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THRUSH; TONSIL CANCER;

BASE SEQUENCE; BETA-DEFENSINS; BETAMETHASONE; CANDIDIASIS; CARCINOMA, SQUAMOUS CELL; EPITHELIAL CELLS; GENE EXPRESSION; HUMANS; HYPERPLASIA; MOLECULAR SEQUENCE DATA; OPPORTUNISTIC INFECTIONS; RNA, MESSENGER; TONSIL; TONSILLAR NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 2442623499     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Wall SD and Jones B: Gastrointestinal tract in the immunocompromised host: opportunistic infections and other complications. Radiology 185(2): 327-35, 1992.
2. De Pauw BE: Practical modalities for prevention of fungal infections in cancer patients. Eur J Clin Microbiol Infect Dis 16(1): 32-41, 1997.
3. Wingard JR: Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin Infect Dis 20(1): 115-25, 1995.
4. Walsh TJ, Lee JW, Roilides E and Pizzo PA: Recent progress and current problems in management of invasive fungal infections in patients with neoplastic diseases. Curr Opin Oncol 4(4): 647-55, 1992.
5. Harder J, Bartels J, Christophers E and Schröder JM: A peptide antibiotic from human skin. Nature 387: 861, 1997.
6. Harder J, Siebert R, Zhang Y, Matthiesen P, Christophers E, Schlegelberger B and Schroder JM: Mapping of the gene encoding human beta-defensin-2 (DEFB2) to chromosome region 8p22-p23.1. Genomics 46(3): 472-5, 1997.
7. Harder J, Meyer-Hoffert U, Teran LM, Bartels J, Maune S and Sehröder JM: Mucoid Pseudomonas aeruginosa, TNF-alpha and IL-1beta, but not IL-6, induces human beta-defensin-2 in respiratory epithelia. Am J Respir Cell Mol Biol 22(6): 714-721, 2000.
8. Schröder JM: Epithelial peptide antibiotics. Biochem Pharmacol 57(2): 121-34, 1999.
9. Krisanaprakornkit S, Weinberg A, Perez CN and Dale BA: Expression of the peptide antibiotic human beta-defensin 1 in cultured gingival epithelial cells and gingival tissue. Infect Immun 66(9): 4222-8, 1998.
10. Krisanaprakornkit S, Kimball JR, Weinberg A, Darveau RP, Bainbridge BW and Dale BA: Inducible expression of human beta-defensin 2 by Fusobacterium nucleatum in oral epithelial cells: multiple signaling pathways and role of commensal bacteria in innate immunity and the epithelial barrier. Infect Immun 68(5): 2907-15, 2000.
11. Dunsche A, Acil Y, Dommisch H, Siebert R, Schröder JM and Jepsen S: The novel human beta-defensin-3 is widely expressed in oral tissues. Eur J Oral Sci 110(2): 121-4, 2002.
12. Mathews M, Jia HP, Guthmiller JM, Losh G, Graham S, Johnson GK, Tack BF and McCray PB Jr.: Production of beta-defensin antimicrobial peptides by the oral mucosa and salivary glands. Infect Immun 67(6): 2740-5, 1999.
13. Bonass WA, High AS, Owen PJ and Devine DA: Expression of beta-defensin genes by human salivary glands. Oral Microbiol Immunol 14(6): 371-4, 1999.
14. Chae SW, Lee SH, Cho JH, Lee HM, Choi G and Hwang SJ: Expression of human beta-defensin 1 mRNA in human palatine tonsil. Acta Otolaryngol 121(3): 414-8, 2001.
15. Weise JB, Meyer JE, Helmer H, Wittrock H and Maune S: A newly discovered function of palatine tonsils in immune defence: the expression of defensins. Otolaryngol Pol 56(4): 409-13, 2002.
16. Dale BA, Kimball JR, Krisanaprakornkit S, Roberts F, Robinovitch M, O'Neal R, Valore EV, Ganz T, Anderson GM and Weinberg A: Localized antimicrobial peptide expression in human gingiva. J Periodontal Res 36(5): 285-94, 2001.
17. Abiko Y, Jinbu Y, Noguchi T, Nishimura M, Kusano K, Amaratunga P, Shibata T and Kaku T: Upregulation of human beta-defensin 2 peptide expression in oral lichen planus, leukoplakia and candidiasis. An immunohistochemical study. Pathol Res Pract 198(8): 537-42, 2002.
18. Duits LA, Rademaker M, Ravensbergen B, van Sterkenburg MA, van Strijen E, Hiemstra PS and Nibbering PH: Inhibition of hBD-3, but not hBD-1 and hBD-2, mRNA expression by corticosteroids. Biochem Biophys Res Commun 280(2): 522-5, 2001.
19. Simmaco M, Boman A, Mangoni ML, Mignogna G, Miele R, Barra D and Boman HG: Effect of glucocorticoids on the synthesis of antimicrobial peptides in amphibian skin. FEBS Lett 416(3): 273-5, 1997.
20. Simmaco M, Mangoni ML, Boman A, Barra D and Boman HG: Experimental infections of Rana esculenta with Aeromonas hydrophila: a molecular mechanism for the control of the normal flora. Scand J Immunol 48(4): 357-63, 1998.
21. Barnes PJ: Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci (Lond) 94(6): 557-72, 1998.
22. Abiko Y, Mitamura J, Nishimura M, Muramatsu T, Inoue T, Shimono M and Kaku T: Pattern of expression of beta-defensins in oral squamous cell carcinoma. Cancer Lett 143: 37-43, 1999.
23. Krogh P, Hald B and Holmstrup P: Possible mycological etiology of oral mucosal cancer: catalytic potential of infecting Candida albicans and other yeasts in production of N-nitrosöbenzylmethylamine. Carcinogenesis 8(10): 1543-8, 1987.
24. Sawaki K, Mizukawa N, Yamaai T, Fukunaga J and Sugahara T: Immunohistochemical study on expression of alpha-defensin and beta-defensin-2 in human buccal epithelia with candidiasis. Oral Dis 8(1): 37-41, 2002.
25. Sawaki K, Mizukawa N, Yamaai T, Yoshimoto T, Nakano M and Sugahara T: High concentration of beta-defensin-2 in oral squamous cell carcinoma. Anticancer Res 22(4): 2103-7, 2002.
26. Mizukawa N, Sawaki K, Yamachika E, Fukunaga J, Ueno T, Takagi S and Sugahara T: Presence of human beta-defensin-2 in oral squamous cell carcinoma. Anticancer Res 20(3B): 2005-7, 2000.